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The enzyme apolipoproteinN-acyltransferase (Lnt) is an inte-
gral membrane protein that catalyzes the last step in the post-
translational modification of bacterial lipoproteins. Lnt under-
goes covalent modification in the presence of phospholipids
resulting in a thioester acyl-enzyme intermediate. It then trans-
fers the acyl chain to the -amino group of the N-terminal dia-
cylglyceryl-modified cysteine of apolipoprotein, leading to the
formationofmature triacylated lipoprotein.To gain insight into
the catalytic mechanism of this two-step reaction, we overpro-
duced andpurified the enzymeofEscherichia coli and studied its
N-acyltransferase activity using a novel in vitro assay. The puri-
fied enzyme was fully active, as judged by its ability to form a
stable thioester acyl-enzyme intermediate and N-acylate the
apo-form of the murein lipoprotein Lpp in vitro. Incorporation
of [3H]palmitate and mass spectrometry analysis demonstrated
that Lnt recognized the synthetic diacylglyceryl-modified lipo-
peptide FSL-1 as a substrate in amixedmicelle assay. Kinetics of
Lnt usingphosphatidylethanolamine as an acyl donor andFSL-1
as a substratewere consistentwith aping-pong typemechanism,
demonstrating slow acyl-enzyme intermediate formation and
rapid N-acyl transfer to the apolipopeptide in vitro. In contrast
to earlier in vitro observations, the N-acyltransferase activity
was strongly affected by the phospholipid headgroup and acyl
chain composition.
The post-translational modification of proteins by covalent
lipid attachment is universal to all organisms. In bacteria, 1–3%
of the genome encodes lipoproteins that are anchored to the
cell envelope, where they fulfill various key functions, such as
maintenance of the cell wall integrity, nutrient uptake, secre-
tion, extra-cytoplasmic protein folding, and virulence (1–7).
Lipoproteins are synthesized as prolipoproteins that are trans-
located across the cytoplasmic membrane via the Sec or the
Twin arginine translocation (Tat) machineries (8–10). With
few exceptions (11), all of them have a hydrophobic signal
peptide that includes a highly conserved amino acid motif,
called the lipobox (Leu(Ala, Val)4-Leu3-Ala(Ser)2-
Gly(Ala)1-Cys1). The invariant cysteine is fatty-acylated by
the sequential action of phosphatidylglycerol:prolipoprotein dia-
cylglyceryl transferase (Lgt), which adds a phosphatidylglycerol-
derived thioether-linked diacylglyceryl residue, and of prolipo-
protein signal peptidase (Lsp), which cleaves the hydrophobic
signal peptide to liberate the -amino group of Cys1. In a final
step, apolipoprotein-N-acyltransferase (Lnt) transfers a prefer-
ential phosphatidylethanolamine-derived sn-1-acyl chain to
the free -amino group of Cys1, resulting in mature tri-acyl-
ated lipoprotein (Fig. 1) (12–15). All three enzymes are essential
for growth and viability of Gram-negative bacteria and are
located in the inner (cytoplasmic) membrane (16–18). In pro-
teobacteria, N-acylation of lipoproteins is a prerequisite for
transfer of lipoproteins to the outer membrane via the Lol
machinery (17, 19, 20). The gene encoding Lnt was originally
identified in Salmonella enterica sv. Typhimurium and is
conserved in proteobacteria and in mycobacteria (21, 22).
Recent findings demonstrated that N-acylated lipoproteins
exist in various staphylococcal species, suggesting that apo-
lipoprotein N-acyltransferase activity is present in firmic-
utes, although an lnt gene could not be identified in the
genomes of this class of bacteria (23, 24).
Initial studies of Escherichia coli Lnt assigned its first enzy-
matic properties, e.g. a pH optimum of 6.5–7.4, thermostability
up to 60 °C, and activity dependence upon the presence of
detergents (14). More recently, it was demonstrated that Lnt is
anchored in the innermembrane by at least six transmembrane
helices with a nitrilase-like periplasmic domain containing the
catalytic triad Glu267–Lys335–Cys387 (17, 22). The formation of
an extra-cytoplasmic thioester acyl-enzyme intermediate sug-
gested that Lnt functions by an initial nucleophilic attack of the
activated thiol of Cys387 on the carbonyl group of the sn-1-acyl
chain of a phospholipid like phosphatidylethanolamine (PE)3
(25). The by-product of this first step, a lysophospholipid (Fig.
1), is flipped across the inner membrane by the lysophospho-
lipid transporter LplT and is recycled by the bifunctional
enzyme 2-acyl-PE acyltransferase/acyl-ACP synthetase (26,
27). In the second step of the Lnt reaction, the acyl-enzyme
intermediate is resolved by the -amino group of an incoming
apolipoprotein.Mycobacterial lipoproteins aremodified with a
diacylglyceryl moiety containing mycobacterium-specific fatty
acids (21). The observation that Lnt of Mycobacterium smeg-
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matis is nonfunctional in E. coli suggests that the diacylglyceryl
group also plays a role in substrate specificity. It is currently not
known how Lnt binds its substrates or how it removes the acyl
group from phospholipids and subsequently attaches it onto a
lipoprotein.Wedeveloped an apolipoproteinN-acyltransferase
in vitro assay based on purified enzyme, a synthetic lipopeptide
substrate and various phospholipid acyl donors. We present
its kinetic parameters and determined specificity of fatty
acid chains and phospholipid headgroups of apolipoprotein
N-acyltransferase.
EXPERIMENTAL PROCEDURES
Chemicals and Materials—[9,10-3H]Palmitate, 5 mCi (185
MBq), were purchased from PerkinElmer Life Sciences. The
cysteine alkylation reagent mPEG-MAL (5 kDa) was obtained
from Creative PEG Works, Winston Salem, NC. All phospho-
lipids used in the study were from Avanti Polar Lipids, Alabas-
ter, AL. The lipopeptide FSL-1-Biotin was obtained from EMC
Microcollections, Tu¨bingen, Germany. Plasmid pASK-IBA3
anhydrotetracycline, Streptactin-Sepharose, and desthiobio-
tin were purchased from IBA GmbH, Go¨ttingen, Germany.
The protease inhibitor 4-(2-aminoethyl) benzenesulfonyl
fluoride hydrochloride was from Interchim SA, Montluc¸on,
France. All molecular biology enzymes were either from
New England Biolabs, Ipswich, MA, or from Fermentas
GmbH, St. Leon Rot, Germany. All other chemicals, includ-
ing oligonucleotides, were either obtained from Sigma or
from Carl Roth GmbH, Karlsruhe, Germany, and were at
least of analytical grade.
Bacterial Strains and Plasmids—All strains and plasmids
used in the study are listed in Table 1. PAP105 was used as an
E. coli strain in all experiments unless indicated otherwise. Plas-
mid pCHAP9510 was generated by cloning a synthetic DNA
fragment (Sigma) encoding the myc tag amino acids in-frame
with the Strep tag sequence of pASK-IBA3 using NcoI and
PstI restriction sites. The lnt gene from E. coli was PCR-
amplified from genomic DNA using the oligonucleotides
Lnt_20a_BsaI (5-GGATAGGGTCTCAAATGGCTTTTGC-
CTCATTAATTG-3) and Lnt_20b_BsaI (5-CACGATG-
GTCTCGGCGCTTTTACGTCGCTGACGCAG-3) as prim-
ers and cloned into the pASK-IBA3 using BsaAI restriction
sites. The Lnt(K335A) and the single cysteine Lnt(Cys387) var-
iant were obtained by PCR using plasmids pCHAP7650 and
pCHAP7556 as templates, respectively (17, 22). PCR fragments
were cloned either in pASK-IBA3 using BsaAI restriction
sites (Lnt(K335A)) or in pCHAP9510 (Lnt(Cys387)) using EcoRI
and XhoI restriction sites.
FIGURE 1. Lipoprotein modification pathway in E. coli. An unmodified prolipoprotein with a hydrophobic signal peptide (SP) containing the conserved
lipobox sequence is first modified by the enzymes phosphatidylglycerol:prolipoprotein diacylglyceryl transferase (Lgt) and prolipoprotein signal peptidase
(Lsp). This apolipoprotein is further modified by apolipoprotein N-acyltransferase (Lnt), which attacks the sn-1 acyl chain of a phospholipid, forms a thioester
acyl-enzyme intermediate, and transfers the acyl group to the -amino group of the diacylglyceryl-cysteine, leading to a mature triacylated lipoprotein. The
acyl donor indicated is based on one of the major E. coli phospholipids, 1-palmitoyl-2-vaccenoyl-sn-glycero-3-phosphoethanolamine (16:0, cis-11,12-18:1).
TABLE 1
Strains and plasmids used in the study
Strain/plasmid Characteristics Source or Ref.
E. coli strains
PAP105 E. coli K-12 (lac-pro) F (lacIq lacZM15 pro Tn10) Laboratory collection
PAP8504 BW25113 ybeX-(kan-rpoCter-paraB)-lnt 17
plasmids
pCHAP7556 pUC18 lnt(C23A,C62A) 25
pCHAP7650 pUC18 lnt(K335A) 22
pASK-IBA3 Expression vector with AHT inducible promoter, Strep-tag, AmpR IBA GmbH
pCHAP9515 pASK-IBA3-lntEc-strep This study
pCHAP9519 pASK-IBA3-lntEc(K335A)-strep This study
pCHAP9523 pASK-IBA3-myc-strep This study
pCHAP9531 pASK-IBA3-lntEc(C23A,C62A)-myc-strep This study
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Growth Conditions for Overproduction of Lnt—Myc-Strep.
E. coli PAP105 with plasmids pCHAP9515, pCHAP9519, or
pCHAP9531 was grown in 10ml of LB with 100gml1 ampi-
cillin from a single colony at 37 °C overnight. This preculture
was used to inoculate 1 liter of LB medium containing 0.1%
glucose, and bacteria were initially grown at 30 °C under aera-
tion at 180 rpm on a rotary shaker. At an A600 of 0.6–0.8, lnt
expression was induced by the addition of anhydrotetracycline
to 100 ng l1, and the culture was transferred to 25 °C, which
allowed further growth, albeit at a drastically lowered rate.
After 4–5 h and at an A600 of 1.3–1.6, cells were harvested by
centrifugation and washed with buffer P1 (20mMTris-HCl, pH
8, containing 150mMNaCl, and 0.5mMEDTA). This bufferwas
used in all subsequent steps, andmodifications are as indicated.
The pellet was used directly for the preparation of membranes
or stored up to 36 h at25 °C.
Membrane Preparation and Solubilization of Lnt—All steps
were carried out at 4 °C. The frozen pellet was resuspended in
25 ml of P1 with 0.1 g ml1 DNase and 0.2 mM 4-(2-amino-
ethyl)benzenesulfonyl fluoride hydrochloride. Cells were bro-
ken by three passages through a French pressure cell at 10,000
p.s.i. Unbroken cells and debriswere removed by centrifugation
at 6,000 g for 10 min. The membrane fraction was prepared
from the supernatant by ultracentrifugation at 120,000 g for
60min. Themembrane pellets were either stored for up to 48 h
at 25 °C or immediately washed and resuspended in 9 ml of
P1. Triton X-100 was added to a final concentration of 2% (v/v)
to solubilize membrane proteins, and the suspension was incu-
bated for 1 h with intermittent inversion on a rotation appara-
tus. All insoluble material was removed by centrifugation at
40,000 g for 30 min.
Protein Purification—Lnt was purified by Strep-Tactin
affinity chromatography using a prepacked Strep-Tactin
Superflow high capacity column (IBA) coupled to an A¨kta
Purifier FPLC system (GE Healthcare). The column was equil-
ibratedwith 2 columnvolumes (CV) of P1 containing 2%Triton
X-100. After binding 10 ml of the Triton X-100-solubilized
membrane fraction, the column was washed with at least 4 CV
of P1 containing 0.1% Triton X-100. A second wash with 4 CV
of P1 containing 0.05% DDM replaced the Triton X-100 as
observed by a decrease in UV absorbance 280 nm. The protein
was eluted from the column with 3 CV of P1 containing 0.05%
DDM and 2.5 mM desthiobiotin. Purity was judged after SDS-
PAGE and staining with Coomassie Brilliant Blue, and the
identity of the protein was confirmed by immunoblotting. The
protein concentration was determined by measuring the ab-
sorbance at 280 nm and by the BCA method using BSA as a
standard. Purified protein was stored in the elution buffer at
25 °C for at least 5 months without a detectable loss in
activity.
Alkylation withMal-PEG—The presence of free thiol groups
in wild type Lnt and the single cysteine Lnt(C23A,C62A) was
determined by their accessibility to the alkylating agent
Maleimide-conjugated polyethylene glycol, 5 kDa (Mal-PEG)
as described previously (25). Briefly, purified protein was incu-
bated at 37 °C in the presence or absence of phospholipids for 5
min and denatured by adding of 0.5% SDS in 1 M Tris-HCl, pH
8. Mal-PEG was added to a final concentration of 0.2 mM and
incubated for 30 min at room temperature. An excess of cys-
teine (2 mM) was added to terminate the reaction. As the Mal-
PEG adds roughly 5 kDa to theirmolecularmass, alkylated pro-
teins could be identified easily by SDS-PAGE followed by
immunoblotting.
Preparation of Apo-Lpp—An lnt conditional null mutant
expressing the lnt gene from an arabinose-inducible promoter
was used to obtain the apo-form of Lpp, essentially as described
earlier (17). Lnt was depleted when cells were grown in LB at
37 °C with D-fucose (0.2% (w/v)) to repress the arabinose pro-
moter. After 8 generations (180 min), growth arrest was
observed, and theA600 remained constant. Cells were harvested
30 min after the growth arrest, which was accompanied by the
accumulation of apolipoprotein. Appearance of the apo-form
of Lpp was confirmed by immunoblotting using polyclonal
anti-Lpp antibodies. Spheroplasts of these sampleswere used to
isolate themembrane fraction that was either frozen or directly
used to analyze Lnt activity.
Lnt in Vitro Assay with Unlabeled Phospholipids—When
apo-Lppwas used as a substrate, the assay was carried out using
the membrane fraction of Lnt-depleted cells as a source of acyl
donor and apolipoprotein substrate.Membranes were added to
a final protein concentration of 250 ng l1 to the standard
reaction buffer composed of 50 mM Tris-HCl, pH 7.2, 150 mM
NaCl, and 0.1% Triton X-100. A reaction mixture of 50 l was
briefly sonicated in a sonicator bath and preincubated at 37 °C
prior to the addition of purified enzyme at 10 ng l1. Samples
were removed at time intervals, and Lnt was rapidly inactivated
by adding 5% SDS and heating to 100 °C. The relative levels of
apo- and mature Lpp were monitored by SDS-PAGE and
immunoblotting using anti-Lpp antibodies.
The standard assay for Lnt activity using the lipopeptide
FSL-1 was carried out in a reaction volume of 20 l containing
commercial phospholipids and FSL-1 at concentrations of 500
and 5 M, respectively. Phospholipids were added as mixed
micelles in 0.1% Triton X-100. Following a brief sonication and
preincubation at 37 °C, 3.5 nM (0.2 ng l1) of Lnt was added.
To determine the initial rates of the Lnt reaction, samples were
taken at least at four time points within the first 120 min of the
reaction. The time course of the first (slow) step of the reaction
was 0, 5, 10, and 20min and of the second (fast) step was 0, 2, 5,
and 10min. Samples of 2l were removed at time intervals and
heat-inactivated in the presence of 5% SDS. Aliquots of the
samples were analyzed by SDS-PAGE and immunoblotting.
Preparation of [3H]Palmitate-labeled Membrane Vesicles—
Radioactive labeling of whole cells was performed as described
previously (25). Cells were grown at 37 °C to A600 0.2, and
[3H]palmitate was added to 100 Ci ml1. After 60 min, cells
were harvested by centrifugation and washed with P1 buffer.
The total membrane fraction was prepared from spheroplasts
as described previously (28). The membranes were heated at
100 °C for 10 min to inactivate endogenous Lnt and stored as
50-l aliquots at25 °C.
LntAssaywith [3H]PalmitateMembraneVesicles—The assay
was performed essentially as described for apo-Lpp, except that
[3H]palmitate-labeled membrane vesicles at 200 nCil1 were
used as source of phospholipids, and the apolipoprotein sub-
strate was 20 ng l1 of FSL-1-Biotin peptide. Following heat
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inactivation of Lnt, FSL-1was purified by its biotin tag using the
streptavidin mutein matrix (Roche Applied Science). Purifica-
tion was carried out according to the manufacturer’s instruc-
tions except that 0.1% of Triton X-100 was added to the wash
and elution buffers. Elutionwas performed in three 100-l frac-
tions that were combined and added to 5 ml of scintillation
liquid (GE Healthcare). Radioactivity incorporation into the
peptide was determined by measuring [3H]palmitate with the
Tri-Carb-2100-TR liquid scintillation analyzer (PerkinElmer
Life Sciences) and was expressed as the percentage of total
radioactivity in the reaction mixture.
SDS-PAGE, Immunoblotting, and Quantification—Purified
Lnt was detected after Tris-glycine-SDS-PAGE (10% acrylam-
ide) and immunoblotted using -Myc, anti-Strep-tag II, and
-Lnt antibodies. Rabbit polyclonal antibodies against Lntwere
raised using purified His-tagged periplasmic domain of the
enzyme as antigen (Genscript). This polypeptide was produced
in inclusion bodies in the cytoplasm and was purified by Co2
affinity chromatography under denaturing conditions. To dis-
tinguish between the diacylglyceryl- and the N-acyldiacylglyc-
eryl forms of Lpp or FSL-1, samples were separated in high
resolution Tricine-buffered SDS-PAGE (29). Acrylamide was
taken from a 40% (w/v) stock solution containing 2.1% of bisa-
crylamide as a cross-linker. The percentage of polyacrylamide
was 6% in the stacking gel and 16.5% for the separating gel. To
enhance the resolution of the different forms of the lipopeptide
FSL-1, 6 M urea was added to the gels, and the 18.5% separating
gel was overlaid by an 11% acrylamide spacer gel. Following
electrophoresis, the proteins were blotted onto nitrocellulose
membranes and hybridized against a streptavidin-peroxidase
conjugate. ECL Plus Western blotting detection reagent (GE
Healthcare) was used as HRP substrate. Fluorescent signals
were detectedwith a Storm840 optical scanner (GEHealthcare)
and quantified using ImageQuant 5.0 (GE Healthcare).
MALDIMeasurements of FSL-1—MALDI analyses were per-
formed to monitor in vitro N-acylation of the FSL-1 peptide by
Lnt. 2,5-Dihydroxybenzoic acid (10 mg ml1) was dissolved in
20% acetonitrile and 0.1% HCOOH. Samples were diluted into
the matrix solution to reach a 10 M concentration of FSL-1.
Crystals were obtained using the dried droplet method with 1
l of each sample.MALDImeasurements were carried out on a
Voyager-DE STR MALDI-TOF mass spectrometer in the pos-
itive reflectron mode (Applied Biosystems, Foster City. CA).
External calibration was applied, and mass spectra were pro-
cessed by Data Explorer software (Applied Biosystems). The
expected mass of FSL-1 (C112H188N20O23S2) is 2245,3598.
RESULTS
Overproduction and Purification of Lnt from E. coli—The lnt
(cutE) gene was modified to allow production of a C-terminal
Myc-Strep-tag II fusion protein in E. coli that was then recov-
ered from themembrane fraction. The proteinwas not released
from the membrane in 2 M NaCl or 6 M urea, as expected for an
integral membrane protein and indicating that overproduction
of Lnt does not result in the accumulation of membrane-asso-
ciated aggregates. The detergents CHAPS, n-octylpolyoxyeth-
ylene, -octyl glucoside, dodecyl maltoside (DDM), and Triton
X-100were tested in concentrations up to 2% (w/v) to solubilize
Lnt. Triton X-100 (2%) was found to be the most efficient of
these detergents, as judged by immunoblotting of detergent-
soluble and -insoluble membrane fractions. This is in agree-
ment with earlier observations that apolipoprotein N-acyl-
transferase activity was detected in Triton X-100-solubilized
E. colimembranes (14). The solubilizedmembrane fractionwas
used directly for purification of Lnt via Strep-Tactin affinity
chromatography. During this procedure, the concentration of
Triton X-100 was either reduced to 0.1% or the detergent was
completely exchanged with 0.05% DDMwithout affecting pro-
tein solubility or enzyme activity. On SDS-PAGE, purified Lnt-
Myc-Strep-tag II migrated as a 54-kDa protein, slightly faster
than its theoretical molecular mass of 61 kDa (Fig. 2A; Ref. 39).
The identity of the fusion protein was confirmed by immuno-
blotting using antibodies against the periplasmic domain of Lnt
and against the myc and strep tag (Fig. 2B) (data not shown).
The purified enzyme preparations were stored in elution buffer
at25 °C for up to 5months without significant loss of activity.
Overall, this protocol yielded up to 1 mg of protein/liter of cell
culture in a single-step purification.
Purified Lnt Exists Mainly in the Nonacylated Form—Lnt
exists as an extra-cytoplasmic acyl-enzyme intermediate in vivo
because of the formation of a stable thioester between the active
site cysteine and a palmitoyl residue, as demonstrated by
[3H]palmitate labeling and by cysteine alkylationwithMal-PEG
(25). To determine whether purified Lnt was in its acylated
form, detergent-solubilized and delipidated enzyme was
treated with Mal-PEG after incubation in the presence or
absence of phospholipids. To facilitate analysis of the acylation
state of Lnt, a variant in which cysteines at positions 23 and 62
were replaced by alanine was also purified. The variant enzyme
Lnt(C23A,C62A)was previously shown to complement fully an
lnt conditional null mutant (25) and to be fully active in vitro
(see below). In the absence of phospholipids, Lnt was modified
by Mal-PEG (5 kDa), resulting in a slower migrating band in
SDS-PAGE (Fig. 2B, lane 2). In the presence of phospholipids,
Lnt was protected from alkylation, indicating that the thioester
blocked the thiol of the active site cysteine (Fig. 2B, lane 4).
Further evidence for the absence of a stable thioester in the
purified enzyme was provided by incubating it with [3H]palmi-
tate phospholipids in labeled membrane vesicles. In this assay,
Lnt formed a stable thioester acyl-enzyme intermediate that
was detected by SDS-PAGE and fluorography (Fig. 2C). These
results showed that purified Lnt is mainly unacylated but in an
active conformation such that it can attack the sn-1-acyl chain
of a phospholipid and become acylated.
Purified Lnt N-Acylates Endogenous Apo-Lpp in Vitro—Lpp
is one of the most abundant proteins in E. coli, exceeding
500,000 molecules per cell (30, 31). Lnt catalyzes the N-acyla-
tion of apo-Lpp in vivo, and its correct lipid modification was
shown to be essential for cell envelope integrity and for viability
(17, 32). Hence, the lipidation intermediates of Lpp have often
been used as model substrates to study lipoprotein modifica-
tion in vitro and in vivo (17, 33, 34). To test whether the deter-
gent-solubilized and -purified Lnt was active under in vitro
conditions, we analyzedN-acylation of apo-Lpp inmixed deter-
gent-phospholipidmicelles. Apo-Lppwas prepared froma con-
ditional lnt null mutant (17). In this strain, the lnt gene is exclu-
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sively expressed from an arabinose-inducible promoter. The
absence of arabinose leads to depletion of Lnt and accumula-
tion of apo-Lpp (17, 22). The apo-form can be distinguished
from the mature (triacylated) form by its faster migration in a
high resolution Tricine-SDS-PAGE (32). Amixture of Lpp spe-
cies corresponding to the mature form, the accumulated apo-
form, andLpp linked to peptides of the peptidoglycan backbone
was detected in vesicles prepared from spheroplasts of Lnt-
depleted cells (Fig. 3A, 0 min). Upon incubation of Lnt with
detergent-solubilized vesicles, apo-Lpp was converted over
time into mature Lpp, as indicated by the disappearance of the
apo-Lpp (Fig. 3A, 0–45 min). These data indicate that Lnt
N-acylated endogenous apolipoprotein in vitro.
Lnt N-Acylates a Synthetic Diacylglyceryl Lipopeptide in
Vitro—Initial attempts to study the kinetics of the apolipopro-
tein N-acyltransferase were hindered by the fact that defined
substrates were unavailable and that entire membranes were
used as the sources of the enzyme. To overcome this problem,
we analyzed whether a synthetic diacylated lipopeptide could
be used as a substrate to study Lnt activity. FSL-1-Biotin
(FSL-1) is a synthetic peptide based on a lipoprotein from
Mycoplasma pneumoniae and has often been used as model
peptide to study the activation of Toll-like receptors (35, 36).
This peptide carries a thioether-linked dipalmitoyl-glyceryl
modification on its N-terminal cysteine residue and contains a
free -amino group, resembling perfectly the N terminus of an
FIGURE2.PurificationofLntand formationof theacyl-enzyme intermediate in vitro.A,SDS-PAGEofprotein fractions atdifferent stagesof Lntpurification.
Proteinswere stainedwithCoomassieBrilliant Blueandmolecularmass standards (M) aregiven in kDa. Lntwasoverproducedandpurified fromthemembrane
fraction (Mbr), solubilized in Triton X-100 (TX100), andbound specifically to a Strep-Tactin column. Afterwashing, purified Lntwas eluted from the column (E).
FT indicates flow-through. See “Experimental Procedures” for details. B, alkylation of Lnt by Mal-PEG. Purified Lnt(C23A,C62A) was incubated in the absence
(lanes 1 and 2) or presence (lanes 3 and 4) of phospholipids (PL) and subsequently treatedwith the thiol-specific alkylation reagentMal-PEG (lanes 2 and 4). Lnt
was detected by immunoblotting using -Myc antibodies. C, purified Lnt forms a palmitoyl enzyme intermediate in vitro. Lnt was added to phospholipid
vesicles isolated from [3H]palmitate-labeled cells and analyzed by SDS-PAGE and fluorography.
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apolipoprotein. When FSL-1 was incubated with Lnt and
[3H]palmitate-labeled heat-inactivated vesicles in the presence
of detergent, more than 10% of total radioactivity was specifi-
cally incorporated into FSL-1 (Fig. 3B). The incorporation of
[3H]palmitate in FSL-1 was strictly dependent on active Lnt,
because [3H]palmitoyl transfer to FSL-1was not observedwhen
using an inactive Lnt variant in which Lys335 was replaced by
Ala (Fig. 3B, dashed line) (22). These data suggested that FSL-1
wasN-acylated by Lnt. To confirm that palmitate was attached
to FSL-1, an Lnt-dependent reaction containing sn-1-(16:0)-2-
(18:1)-PE was analyzed by MALDI-TOF mass spectrometry.
The m/z 2246.4 peak corresponding to FSL-1 (average mass
accuracy 30 ppm)was detected both in the absence and in the
presence of Lnt. In contrast, the m/z 2484.7 peak was only
observed after completion of the reaction with Lnt (Fig. 4). The
mass shift of 238.3 between the two peaks demonstrated that
Lnt catalyzed the N-palmitoylation of FSL-1 (expected mass of
palmitoyl moiety 238.4 Da). Similar results were obtained by
electrospray ionization-MS analyses (data not shown). These
data provided direct evidence that the FSL-1 lipopeptide is rec-
ognized as an Lnt substrate in vitro and also confirmed that the
sn-1-acyl chain (C16:0, 238.4 Da) and not the sn-2-chain (C18:1
and 264.4 Da) is transferred from the phospholipid to the N
terminus of apolipoprotein.
Enzymatic Properties of Lnt—The use of FSL-1 and chemi-
cally defined phospholipids together with purified Lnt facili-
tated studies on the substrate and acyl donor specificity and
allowed the determination of kinetic parameters. Time-depen-
dent N-acylation using polar lipid extract from E. coli (Fig. 5A)
or synthetic phospholipids as acyl donors was analyzed on high
resolution Tricine-SDS-PAGE followed by blotting onto nitro-
cellulose membranes and detection of biotinylated FSL-1 using
a streptavidin-peroxidase conjugate. In the absence of enzyme
or phospholipids, FSL-1 migrated aberrantly with an apparent
size of 5 kDa, despite its theoretical molecular mass of 2246
Da that was confirmed byMALDI and electrospray ionization-
MS. Addition of Lnt resulted in a time-dependent appearance
of a slightly slower migrating variant of the peptide, corre-
sponding to the N-acylated form of FSL-1 (Fig. 5A). The quan-
FIGURE 3. Purified Lnt is functional in vitro. A, Lnt N-acylates apo-Lpp in
vitro. Purified Lnt was incubated with detergent-solubilized membrane vesi-
cles derived from Lnt-depleted cells containing apo-Lpp as substrate and
phospholipids (PL) as acyl donors. Samples were taken at different time
points and analyzed by Tricine-SDS-PAGE and immunoblotting using anti-
Lpp antibodies. Asterisks indicate Lpp covalently cross-linked to peptidogly-
can fragments. B, Lnt-dependent [3H]palmitoyl incorporation in FSL-1. The
diacylglyceryl-lipopeptide FSL-1 was mixed with phospholipid vesicles iso-
lated from [3H]palmitate-labeled cells. Following the addition of Lnt (E) or
inactive Lnt(K335A) (‚), the reaction mixture was incubated at 37 °C, and
sampleswere removedat time intervals. Thepeptidewaspurified via strepta-
vidin-biotin affinity, and [3H]palmitate incorporationwasdeterminedby scin-
tillation counting. Theamountof [3H]palmitate incorporated into thepeptide
is expressed as a percentage of the total amount of radioactivity in the reac-
tion mixture from three independent experiments.
FIGURE 4. In vitro N-palmitoylation of FSL-1 by Lnt. Comparison of MALDI
mass spectra of FSL-1 after the N-acylation reaction in the absence (upper
panel) and in the presence (lower panel) of Lnt. Them/z 2200–2600 region of
the MALDI spectra is shown, and only monoisotopic significant peaks (S/N
ratio -3) are annotated. Y axis represents the relative signal intensity. a
peaks correspondmost probably to a secondary product of the FSL-1 synthe-
sis (m/z 2230.38) and itsN-palmitoylated form (m/z 2468.63). b peaks are
sodium adducts of FSL-1 and N-palmitoyl-FSL-1 peptides.
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tification of the ratio between diacylated and triacylated FSL-1
over time revealed a typical progress curve of an enzymatic
reaction in which almost all FSL-1 was converted to theN-acy-
lated form (Fig. 5B). The enzyme was fully dependent on the
presence of detergent. Triton X-100 was reported earlier to be
the optimal detergent for the conservation of Lnt activity in
membrane preparations of E. coli (33).When the standard con-
centration of 0.5 mM sn-1-(16:0)-2-(18:1)-PE was used as an
acyl donor in the assay, the highest enzymatic activity was seen
at Triton X-100 concentrations reaching from 0.05 to 0.1%
(0.8–1.6 mM) (Fig. 5C). Triton X-100 at 0.1% exceeded the crit-
ical micelle concentration by a factor of 6–8 leading to a deter-
gent-phospholipid ratio of 3:1 andwasmaintained as the stand-
ard detergent concentration in all assays.
The existence of an acyl-enzyme intermediate in vivo (Fig.
2B) (25) and in vitro (Fig. 2C) suggested a two-step reaction via
a “ping-pong” mechanism, where the initial attack of the phos-
pholipid induces the formation of the intermediate (ping) and is
followed by theN-acyl transfer to the apolipoprotein (pong). To
verify that kinetics were consistent with this type of mecha-
nism, the acyl donor concentrations were varied with different
constant concentrations of FSL-1.Whenplotting the reciprocal
of V0 versus the reciprocal of the sn-1-(16:0)-2-(18:1)-PE con-
centration, parallel lines were obtained (Fig. 6). These results
show that the N-acyl transfer catalyzed by Lnt proceeds via
ping-pong mechanism.
Kinetics and Polar Headgroup Specificity—Previous in vivo
studies on the site-specific turnover of PE and, more recently,
acyl transfer from phospholipids carrying acyl chains selec-
tively labeled with [14C]palmitate or [3H]palmitate demon-
strated that the sn-1-acyl chain is the primary acyl donor for Lnt
(15, 19). This was further confirmed here by mass spectrome-
try. The mechanism, however, by which Lnt recognizes phos-
pholipids as acyl donor is still unknown. It has been proposed
that Lnt does not show any preference for a particular type of
phospholipid with respect to headgroup structure or acyl chain
length and composition. This proposal was based on the obser-
vation that PE, themajor phospholipid in E. coli, was not essen-
tial for theN-acylation of lipoproteins in vivo and that all three
phospholipids of E. coli (PE, PG, and cardiolipin) could serve as
acyl donors in vitro (14, 37). The broad specificity of Lnt was
further supported by a nonkinetic analysis using purified Lnt
(19).
The in vitro Lnt assay using FSL-1 as an acceptor peptide
allowed us to determineN-acylation kinetics in the presence of
defined phospholipids. In a first approach, phospholipid-de-
FIGURE 5. LntN-acylation activity with FSL-1. A, Lnt (10 nM) was added to a reactionmixture composed of polar lipid extract from E. coli (500M) and FSL-1
(60 M). Samples were removed at time intervals from the reaction and analyzed by Tricine-SDS-PAGE and immunoblotting against the biotin tag of FSL-1.
B, concentration of N-acylated FSL-1 in the reaction is represented as a function of time. C, initial rates of N-acylation activity under standard assay conditions
(see “Experimental Procedures”) were strictly dependent on the presence of detergent and are displayed as function of the concentration of Triton X-100.
FIGURE 6. Lnt follows a “ping-pong” mechanism. Double-reciprocal plot
showing initial Lnt activities at various concentrations of sn-1-(16:0)-sn-2-(18:
1)-PE (100–500M) as an acyl donor and three fixed concentrations (1, 5, and
10 M) of FSL-1 as the N-acyltransferase substrate.
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pendent recognition was analyzed by using pure PE, PG, PC,
phosphatidylserine, or PA, all possessing identical diacylglycer-
ide structures with palmitoyl (C16:0) and oleoyl (C18:1) resi-
dues as acyl chains in the sn-1 and sn-2 position, respectively,
representing one of themost common acyl chain combinations
in E. coli (38). As a result of the different biophysical properties
of each of the phospholipids, we initially testedwhich phospho-
lipid concentrations supported optimal enzyme activity under
standard assay conditions (0.1% Triton X-100, 5M FSL-1, and
3.5 nM Lnt). PE and PG showed similar profiles with highest
enzyme activities determined at a concentration of 500M (Fig.
7A). At this concentration, relatively low activity was seen with
PA compared with its narrow optimum around 100 M. Over-
all, N-acyltransferase activity was only observed with four dif-
ferent phospholipids under standard assay conditions (Fig. 7B).
PE was most effective with a Km value for FSL-1 of 8.0 M.
Accordingly, the Vmax value was determined as 350 molFSL-1
min1 mol1Lnt, corresponding to a specific activity of 5.6	
0.3 molFSL-1 min1 mg1Lnt. PG and PA also served as acyl
donors, albeit at reduced rates. Their Km and Vmax values were
10.4Mand 127molFSL-1min1mol1Lnt for PGand 3.8M
and 106 molFSL-1 min1 mol1Lnt for PA, respectively. The
catalytic efficiencies of the enzyme in the presence of these
three phospholipids were similar with kcat/Km values ranging in
the same order ofmagnitudewith 7.3 105 for PE, 4.8 105 for
PA, and 2.0 105 for PG.Only trace activitywas observedwhen
using PC (Km:,18.2 M; Vmax, 27 molFSL-1 min1 mol1Lnt;
and kcat/Km, 9.2  102 M1 s1). For phosphatidylserine,
enzyme activity was below detection limits (data not shown).
Variations in the length and composition of the acyl chains on
PC did not increase FSL-1 N-acylation. This result provided
additional evidence that the polar headgroup plays a crucial
role in recognition by Lnt and that differences in micelle-phos-
pholipid structure did not account for reduced activity.
Acyl Chain Specificity—In a second approach, we studied the
effect of the acyl chain length and composition on Lnt activity
by monitoring the formation of the thioester acyl-enzyme
intermediate. After incubation with standard PE carrying sn-1-
(16:0) and sn-2-(18:1) acyl chains, Lnt was largely inaccessible
to alkylation by Mal-PEG (Fig. 8A, 3rd lane). This result sug-
gested that formation of the acyl-enzyme thioester intermedi-
ate was most efficient with this phospholipid, in agreement
with optimal enzyme activity observed under these conditions
(Figs. 7B and 8B). Similar results were obtained when PE with
acyl chains shorter than 16 carbons or with two unsaturated
C16 acyl chains were used (Fig. 8A, 4th and 6th lanes). Acyl-
enzyme intermediate formation did not occur when sn-1,2-(16:
0)-PE, sn-1,2-(18:0)-PE, or branched hydrocarbon chains like
archaeal type phytanyl residues (sn-1,2-(16:0;4ME)-PE) were
used (Fig. 8A, 5th, 7th, and 8th lanes). To analyze acyl chain-de-
pendent phospholipid recognition by Lnt in more detail, we
used the kinetic assay with various concentrations for each type
of PE (Fig. 8B). The ability to form a thioester acyl-enzyme
intermediate with different types of PE was reflected by their
kinetics. Highest activity relative to standard PE (sn-1-(16:0)-
sn-2-(18:1), kcat/Km: 4.8  103 M1 s1, Km: 462 M, kcat: 2.2)
was observed with PE carrying a saturated C18 on sn-1 and an
unsaturated C18 on sn-2 (sn-1-(18:0)-sn-2-(18:1), kcat/Km,
2.0 103 M1 s1;Km, 2941M; kcat, 6.0). PE with sn-1,2-(12:0)
or with sn-1,2-(16:1) acyl chains served as functional acyl
donors albeit with reduced efficiencies with kcat/Km values of
8.5 102 and 8.9 102 M1 s1, respectively. The correspond-
ing Km and kcat values were determined as 476 M and 0.4 s1
(12:0) and 363M and 0.3 s1 (16:1), respectively. Furthermore,
sn-1-(16:0) lysophosphatidic acid, which lacks an sn-2 acyl
chain, did not serve as a donor. As expected, activity with
sn-1,2-(16:0)-PE, sn-1,2-(18:0)-PE, and sn-1,2-(16:0;4ME)-PE
was below detection limits (data not shown). These data indi-
cate that also the nontransferred sn-2 acyl chain plays an impor-
tant role in acyl donor recognition.
DISCUSSION
The enzyme apolipoprotein N-acyltransferase (Lnt) cata-
lyzes the phospholipid dependentN-acylation of bacterial lipo-
FIGURE7.Kinetics andphospholipidheadgroupspecificityof Lnt.A, time-
dependent formation of N-acyl-FSL-1 using PE (500M), PG (500M), and PA
(100M) as acyl donors was analyzed by Tricine-SDS-PAGE and immunoblot-
ting. Structures of the headgroups of PE, PA, and PG are displayed with R
indicating the 1-palmitoyl-2-oleoyl-sn-glyceryl group. B, initial Lnt activities
are displayed as function of the phospholipid concentration using PE (E), PA
(Œ), and PG (). C, double-reciprocal plot showing initial Lnt activities with
FSL-1 at various concentrations (1–5 M) using either PE, PG, PC (500 M,
dashed line), or PA (100 M) as acyl donor. Data points represent averages of
three independent experiments.
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proteins, resulting in mature triacylated protein (14, 19). To
gain deeper insight into this unique two-step reaction mecha-
nism, we developed a quantitative in vitro assay that allowed us
to determine kinetic parameters and acyl donor specificity. In
cell extracts, Lnt exists mainly as a thioester acyl-enzyme inter-
mediate with a stable thioester link between a fatty acid residue
and the active site cysteine (22, 25). The purified enzyme was
mainly nonacylated, as indicated by the fact that the active site
thiol was accessible to alkylation by Mal-PEG. It is likely that
the acyl-enzyme intermediate resolves during purification as a
result of the lipid-detergent exchange. The purified enzyme
could reform a stable thioester in the presence of phospholipids
as demonstrated by [3H]palmitate labeling and cysteine inac-
cessibility to alkylation. Auto-acylation of Lnt and the forma-
tion of mature Lpp in vitro illustrated that Lnt remained in an
overall active conformation upon purification and reconstitu-
tion in detergent micelles. We used the small dipalmitoylglyc-
eryl-modified lipopeptide FSL-1 as a substrate to study the
kinetics of N-acylation. This modification was sufficient for its
recognition by Lnt, as shown by incorporation of [3H]palmitate
and also demonstrated directly using mass spectrometry.
Lnt catalyzes a unique two-step reaction, the kinetics of
which are in agreement with a ping-pong type mechanism.
Kinetic parameters were determined for each of the two steps
using standard PE (sn-1-(16:0)-sn-2-(18:1)) as acyl donor and
FSL-1 as substrate. The determined kcat/Km value for the sec-
ond step exceeded the one for the thermodynamically unfavor-
able first step of the reaction in which the oxygen ester-linked
sn-1 acyl group of PE is transferred to the Cys387 thiol, by more
than 2 orders ofmagnitude (4.8 103 for PE versus 7.3 105 for
FSL-1). Lnt is thus highly efficient in the second step that
involves binding of the apolipopeptide andN-acyl transfer. The
fact that Lnt exists as a stable acyl-enzyme intermediate in vivo
reflects the large differences in concentration and accessibility
between the two substrates, phospholipids and apolipoprotein.
The determined Vmax value for Lnt of E. coli led us to predict
that 100–200 molecules of enzyme would be sufficient to
achieve the N-acylation of all Lpp produced per cell (500,000)
during one generation of growth suggesting that the enzyme is
of low abundance but is highly efficient. Only few described
membrane-bound acyltransferases use phospholipids as acyl
donors. The lecithin-retinol acyltransferase transfers the sn-1-
acyl chain fromPC to retinol and, like Lnt, proceeds through an
acyl-enzyme intermediate (40, 41). PC-dependentN-acyltrans-
ferase activity was reported for a very similar enzyme, the leci-
thin-retinol acyltransferase-like protein RLP-1, which is
involved in the synthesis of precursors for bioactiveN-acyletha-
nolamines (42). The specific activities reported for both
enzymes are at least 1 or 2 orders ofmagnitude lower than those
determined for Lnt (42, 43). A prominent example of another
membrane-bound bacterial acyltransferase is PagP. This
enzyme is an integral outer membrane protein that transfers
the sn-1-palmitoyl chain derived from PE to a lipid A molecule
with 2 units of 3-deoxy-D-manno-2-octulosonic acid linked at
FIGURE 8. Phospholipid acyl chain specificity of Lnt. A, acyl-enzyme intermediate formation in the presence of PE with different acyl chain lengths and
composition. Lnt(C23A,C62A) was incubated in the presence of phospholipids for 10 min and subsequently treated with the cysteine-specific alkylation
reagentMal-PEG. Sampleswere analyzedby SDS-PAGE and immunoblotting using-Myc antibodies. B,double-reciprocal plot showing the initialN-acyltrans-
ferase activities of Lnt with 5M FSL-1 as an acceptor and PE with different acyl compositions as acyl donors (sn-1-(16:0)-sn-2-(18:1), E; sn-1-(18:0)-sn-2-(18:1),
Œ; sn-1-(16:1)-sn-2-(16:1),; sn-1-(12:0)-sn-2-(12:0), F) (40–500 M).
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the 6 position (44). When sn-1-(16:0)-sn-2-(18:1)-PE was used
as an acyl donor in the presence ofTritonX-100, PagP catalyzed
theO-acylation of lipidA at a rate of 7.22molmin1mg1PagP
(45). Using the same phospholipid as an acyl donor, similar
kinetics (5.6 molFSL-1 min1 mg1Lnt) were determined for
the N-acyltransferase activity of Lnt. Despite a completely
different second step reaction, amide versus acyloxoacyl for-
mation, both acyltransferases showed comparable enzy-
matic activities that are well reflected by the high abundance
of their substrates, 5  105 for Lpp (30, 31) and 2  106 for
lipid A (46).
Lnt was reported to accept a wide range of phospholipid
acyl donors in vivo (15, 37). Here, we addressed its acyl donor
specificity in more detail using the in vitro assay. PE was
most efficient of the phospholipids tested in theN-acyltrans-
ferase reaction, which is not very surprising, because PE was
reported to be the preferred acyl donor of Lnt in vivo (15). In
exponentially growing E. coli cells, PE constitutes between
70 and 80% of cellular phospholipids, making it by far the
most abundant component of the membrane (38). Both PG
and PA supported apolipoprotein N-acyltransferase activity,
although less efficiently than PE. PG is the second most
abundant E. coli phospholipid (20%), and a mutant lacking
PE apparently N-acylated lipoproteins normally, providing
evidence that PG can substitute for PE in vivo (37). PA, a
minor component of E. coli membranes (0.2%), is a key
intermediate in phospholipid metabolism that accumulates
in the absence of PG and is thought to compensate for it in
the recruitment of peripheral membrane proteins (49).
Phospholipids carrying small headgroups (PE and PG) are
preferred over those with more bulky ones (phosphatidylser-
ine and PC). Phospholipid recognition by Lnt was also
dependent on the length and composition of the acyl chains.
Enzyme activity and acyl enzyme formation was significant
only when unbranched acyl chains in position sn-1 were
accompanied by unsaturated ones in position sn-2, with the
exception of short chain acyl groups (12:0). The length of the
acyl chain in position sn-1 was less important as similar cat-
alytic efficiencies were determined when either C16:0 or
C18:0 at sn-1 was combined with C18:1 at sn-2. Fukuda et al.
(19) showed that Lnt from E. coli has a broad specificity of
fatty acyl chains using N-acylation of apo-Pal by Lnt in vitro.
Phospholipids with varying chain lengths and degrees of sat-
uration (C6:0 to C22:6) and different phospholipid head-
groups were used, but the rate of N-acylation was not deter-
mined, which might explain their observation that all
phospholipids serve equally well as substrates for Lnt.
Fatty acid specificity of acyltransferases is generally based on
the presence of amino acid motifs that act as acyl chain binding
pockets. These hydrocarbon rulers were identified as highly
selective determinants for the recognition of the transferred
sn-1 acyl chain by the phospholipid-dependent PagP and two
soluble enzymes involved in lipid A metabolism, LpxA and
LpxD (46–48). It is unlikely that Lnt employs a similar mecha-
nism, as the enzyme seems to be less selective for the length of
the sn-1 acyl chains. Although the role of the sn-2 position in
phospholipid recognition is currently not clear, it has been
reported for PagP that an oleate residue (C18:1) at this position
was beneficial for enzyme activity (45). Future structural anal-
ysis of the enzyme will elucidate how the acyl chain is bound to
Lnt.
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